Compare INBK & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INBK | GLSI |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | 13 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.0M | 254.7M |
| IPO Year | 2013 | 2020 |
| Metric | INBK | GLSI |
|---|---|---|
| Price | $27.11 | $17.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $30.90 | ★ $57.00 |
| AVG Volume (30 Days) | 37.0K | ★ 88.7K |
| Earning Date | 10-21-2026 | 11-13-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $11,541,000.00 | N/A |
| Revenue This Year | $18.94 | N/A |
| Revenue Next Year | $14.34 | N/A |
| P/E Ratio | $47.40 | ★ N/A |
| Revenue Growth | ★ 101.84 | N/A |
| 52 Week Low | $17.05 | $7.78 |
| 52 Week High | $31.09 | $34.10 |
| Indicator | INBK | GLSI |
|---|---|---|
| Relative Strength Index (RSI) | 39.74 | 54.23 |
| Support Level | $25.04 | $17.96 |
| Resistance Level | $30.04 | $19.97 |
| Average True Range (ATR) | 0.89 | 1.30 |
| MACD | -0.16 | 0.08 |
| Stochastic Oscillator | 40.87 | 55.64 |
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.